Dittamore; Ryan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dittamore; Ryan.The latest application filed is for "methods of determining therapies based on single cell characterization of circulating tumor cells (ctcs) in metastatic disease".

Company Profile

3.2.24

Dittamore; Ryan - San Diego CA
Dittamore; Ryan - Tucson AZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Determining Therapies Based On Single Cell Characterization Of Circulating Tumor Cells (ctcs) In Metastatic Disease App 20220260574 - Dittamore; Ryan	2022-08-18
Intra-patient Genomic Heterogeneity Of Single Circulating Tumor Cells (ctcs) Associated To Phenotypic Ctc Heterogeneity In Metastatic Castrate Resistant Prostate Cancer (mcrpc) App 20220162706 - Dittamore; Ryan ; et al.	2022-05-26
Circulating Tumor Cell Diagnostics For Biomarkers Predictive Of Resistance To Androgen Receptor (ar) Targeted Therapies App 20220091124 - Dittamore; Ryan	2022-03-24
Circulating Tumor Cell Diagnostics For Identification Of Resistance To Androgen Receptor Targeted Therapies App 20220091123 - Dittamore; Ryan	2022-03-24
Single Cell Genomic Profiling Of Circulating Tumor Cells (ctcs) In Metastatic Disease To Characterize Disease Heterogeneity App 20210405055 - Dittamore; Ryan ; et al.	2021-12-30
Detection Of Prostate Specific Membrane Antigen (psma) Expression On Circulating Tumor Cells (ctc) App 20210382057 - Dittamore; Ryan	2021-12-09
Methods For The Detection And Quantification Of Circulating Tumor Cell Mimics App 20210373026 - Dittamore; Ryan	2021-12-02
Circulating Tumor Cell Diagnostics For Prostate Cancer Biomarkers App 20200333345 - Dittamore; Ryan	2020-10-22
Circulating tumor cell diagnostics for prostate cancer biomarkers Grant 10,527,624 - Dittamore J	2020-01-07
Androgen Receptor Variant 7 As A Biomarker For Treatment Selection In Patients With Metastatic Castration Resistant Prostate Can App 20190285636 - Dittamore; Ryan	2019-09-19
Single Cell Genomic Profiling Of Circulating Tumor Cells (ctcs) In Metastatic Disease To Characterize Disease Heterogeneity App 20190025312 - Dittamore; Ryan ; et al.	2019-01-24
Single Cell Genomic Profiling Of Circulating Tumor Cells (ctcs) In Metastatic Disease To Characterize Disease Heterogeneity App 20180321247 - Dittamore; Ryan ; et al.	2018-11-08
Automated analysis of circulating tumor cells Grant 10,082,508 - Pestano , et al. September 25, 2	2018-09-25
Intra-patient Genomic Heterogeneity Of Single Circulating Tumor Cells (ctcs) Associated To Phenotypic Ctc Heterogeneity In Metastatic Castrate Resistant Prostate Cancer (mcrpc) App 20180155794 - Dittamore; Ryan ; et al.	2018-06-07
Circulating Tumor Cell Diagnostics For Biomarkers Predictive Of Resistance To Androgen Receptor (ar) Targeted Therapies App 20180052167 - Dittamore; Ryan	2018-02-22
Circulating Tumor Cell Diagnostics For Identification Of Resistance To Androgen Receptor Targeted Therapies App 20170285035 - Dittamore; Ryan	2017-10-05
Circulating Tumor Cell Diagnostics For Therapy Targeting Pd-l1 App 20170242016 - DITTAMORE; Ryan	2017-08-24
Automated Analysis Of Circulating Tumor Cells App 20160349262 - Pestano; Gary ; et al.	2016-12-01
Methods For The Detection And Quantification Of Circulating Tumor Cell Mimics App 20160341732 - Dittamore; Ryan	2016-11-24
Circulating Tumor Cell Diagnostics For Detection Of Neuroendocrine Prostate Cancer (nepc) App 20160040245 - DITTAMORE; Ryan	2016-02-11
Circulating Tumor Cell Diagnostics For Prostate Cancer Biomarkers App 20160033508 - DITTAMORE; Ryan	2016-02-04
Detection Of Prostate Specific Membrane Antigen (psma) Expression On Circulating Tumor Cells (ctc) App 20160011198 - DITTAMORE; Ryan	2016-01-14
Circulating Tumor Cell Diagnostics For Biomarkers Predictive Of Resistance To Androgen Receptor (ar) Targeted Therapies App 20150212089 - DITTAMORE; Ryan	2015-07-30
Automated Analysis Of Circulating Tumor Cells App 20130171642 - Pestano; Gary ; et al.	2013-07-04
Presence of ERG Gene Rearrangements and Protein Over-expression in Low Grade PIN (LG-PIN) in Prostate Biopsies App 20120220672 - Pestano; Gary ; et al.	2012-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.